These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9334882)

  • 1. Effects of sucralfate and its components on acid- and pepsin-induced damage to rat gastric epithelial cells.
    Furukawa O; Matsui H; Suzuki N
    Jpn J Pharmacol; 1997 Sep; 75(1):21-5. PubMed ID: 9334882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel cell damage model induced by acid and pepsin using rat gastric epithelial cells: protective effect of sucralfate.
    Furukawa O; Nakamura E; Okabe S
    J Gastroenterol Hepatol; 1997 Feb; 12(2):115-21. PubMed ID: 9083912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary culture of rat gastric epithelial cells as an in vitro model to evaluate antiulcer agents.
    Zheng H; Shah PK; Audus KL
    Pharm Res; 1994 Jan; 11(1):77-82. PubMed ID: 8140059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.
    Romano M; Razandi M; Ivey KJ
    Dig Dis Sci; 1990 Apr; 35(4):467-76. PubMed ID: 2318093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sucralfate and its components on indomethacin-induced damage to cultured rabbit gastric mucosal cells.
    Takahashi S; Okabe S
    J Physiol Pharmacol; 1996 Dec; 47(4):611-9. PubMed ID: 9116328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of peptic activity by sucralfate.
    Samloff IM; O'Dell C
    Am J Med; 1985 Aug; 79(2C):15-8. PubMed ID: 3929601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotective effect of epidermal growth factor on acid- and pepsin-induced damage to rat gastric epithelial cells: roles of Na+/H+ exchangers.
    Furukawa O; Okabe S
    J Gastroenterol Hepatol; 1997 May; 12(5):353-9. PubMed ID: 9195380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sucralfate (Ulcogant). The mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(47-48):2197-200concl. PubMed ID: 6423500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sucralfate on vacuolating cytotoxin activity and adherence of Helicobacter pylori to human gastric epithelial cells.
    Smoot DT; Earlington MH; Abebe E; Desbordes BC; Murigande C; Naab T
    J Assoc Acad Minor Phys; 1996; 7(4):88-92. PubMed ID: 8936934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative mechanisms of cytoprotective effect of certain antacids and sucralfate.
    Vergin H; Kori-Lindner C
    Dig Dis Sci; 1990 Nov; 35(11):1320-7. PubMed ID: 2226092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):117-27. PubMed ID: 6798100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats.
    Nagahama K; Yamato M; Nishio H; Takeuchi K
    Dig Dis Sci; 2006 Feb; 51(2):303-9. PubMed ID: 16534673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sucralfate protects the ulcer from acids and pepsin].
    von Bocko Polach U
    Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
    [No Abstract]   [Full Text] [Related]  

  • 19. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate.
    Slomiany BL; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1985 Sep; 20(7):857-60. PubMed ID: 3931205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.